nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP3A4—bone cancer	0.858	1	CbGaD
Dorzolamide—Brinzolamide—CYP3A4—bone cancer	0.00684	1	CrCbGaD
Dorzolamide—Abnormal dreams—Doxorubicin—bone cancer	0.000668	0.00493	CcSEcCtD
Dorzolamide—Tinnitus—Cisplatin—bone cancer	0.000666	0.00492	CcSEcCtD
Dorzolamide—Pulmonary oedema—Epirubicin—bone cancer	0.00065	0.0048	CcSEcCtD
Dorzolamide—Arrhythmia—Cisplatin—bone cancer	0.000638	0.00471	CcSEcCtD
Dorzolamide—Blood urea increased—Doxorubicin—bone cancer	0.000638	0.00471	CcSEcCtD
Dorzolamide—Alopecia—Cisplatin—bone cancer	0.000631	0.00466	CcSEcCtD
Dorzolamide—Dry eye—Doxorubicin—bone cancer	0.000624	0.00461	CcSEcCtD
Dorzolamide—Erythema—Cisplatin—bone cancer	0.000622	0.00459	CcSEcCtD
Dorzolamide—Pulmonary oedema—Doxorubicin—bone cancer	0.000602	0.00444	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Methotrexate—bone cancer	0.0006	0.00443	CcSEcCtD
Dorzolamide—Visual disturbance—Methotrexate—bone cancer	0.000598	0.00442	CcSEcCtD
Dorzolamide—Eye pain—Epirubicin—bone cancer	0.000587	0.00434	CcSEcCtD
Dorzolamide—Vision blurred—Cisplatin—bone cancer	0.000586	0.00433	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Epirubicin—bone cancer	0.000585	0.00432	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Methotrexate—bone cancer	0.000578	0.00427	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Epirubicin—bone cancer	0.000562	0.00415	CcSEcCtD
Dorzolamide—Eye pain—Doxorubicin—bone cancer	0.000543	0.00401	CcSEcCtD
Dorzolamide—Hypoglycaemia—Epirubicin—bone cancer	0.000543	0.00401	CcSEcCtD
Dorzolamide—Cardiac failure—Epirubicin—bone cancer	0.000543	0.00401	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Epirubicin—bone cancer	0.000541	0.004	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Doxorubicin—bone cancer	0.000541	0.004	CcSEcCtD
Dorzolamide—Mood swings—Methotrexate—bone cancer	0.000537	0.00396	CcSEcCtD
Dorzolamide—Diplopia—Epirubicin—bone cancer	0.00053	0.00392	CcSEcCtD
Dorzolamide—Pain in extremity—Epirubicin—bone cancer	0.00053	0.00392	CcSEcCtD
Dorzolamide—Anxiety—Cisplatin—bone cancer	0.000528	0.0039	CcSEcCtD
Dorzolamide—Discomfort—Cisplatin—bone cancer	0.000523	0.00386	CcSEcCtD
Dorzolamide—Affect lability—Epirubicin—bone cancer	0.000522	0.00385	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00052	0.00384	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00051	0.00377	CcSEcCtD
Dorzolamide—Anaphylactic shock—Cisplatin—bone cancer	0.000507	0.00375	CcSEcCtD
Dorzolamide—Oedema—Cisplatin—bone cancer	0.000507	0.00375	CcSEcCtD
Dorzolamide—Cardiac arrest—Epirubicin—bone cancer	0.000504	0.00372	CcSEcCtD
Dorzolamide—Hypoglycaemia—Doxorubicin—bone cancer	0.000503	0.00371	CcSEcCtD
Dorzolamide—Cardiac failure—Doxorubicin—bone cancer	0.000503	0.00371	CcSEcCtD
Dorzolamide—Mood swings—Epirubicin—bone cancer	0.000502	0.00371	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—bone cancer	0.000501	0.0037	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—bone cancer	0.000491	0.00362	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—bone cancer	0.000491	0.00362	CcSEcCtD
Dorzolamide—Hyperhidrosis—Cisplatin—bone cancer	0.000491	0.00362	CcSEcCtD
Dorzolamide—Anorexia—Cisplatin—bone cancer	0.000484	0.00357	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—bone cancer	0.000483	0.00357	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000477	0.00353	CcSEcCtD
Dorzolamide—Hypotension—Cisplatin—bone cancer	0.000474	0.0035	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—bone cancer	0.000467	0.00345	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—bone cancer	0.000465	0.00343	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000462	0.00341	CcSEcCtD
Dorzolamide—Influenza—Epirubicin—bone cancer	0.000458	0.00338	CcSEcCtD
Dorzolamide—Dysuria—Methotrexate—bone cancer	0.000458	0.00338	CcSEcCtD
Dorzolamide—Paraesthesia—Cisplatin—bone cancer	0.000456	0.00337	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Methotrexate—bone cancer	0.000455	0.00336	CcSEcCtD
Dorzolamide—Dyspnoea—Cisplatin—bone cancer	0.000452	0.00334	CcSEcCtD
Dorzolamide—Erectile dysfunction—Methotrexate—bone cancer	0.000451	0.00333	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—bone cancer	0.000446	0.0033	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000442	0.00326	CcSEcCtD
Dorzolamide—Decreased appetite—Cisplatin—bone cancer	0.000441	0.00326	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—bone cancer	0.000441	0.00325	CcSEcCtD
Dorzolamide—Depression—Methotrexate—bone cancer	0.000435	0.00322	CcSEcCtD
Dorzolamide—Pain—Cisplatin—bone cancer	0.000434	0.0032	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000433	0.0032	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—bone cancer	0.000429	0.00316	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Epirubicin—bone cancer	0.000426	0.00315	CcSEcCtD
Dorzolamide—Conjunctivitis—Methotrexate—bone cancer	0.000424	0.00313	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—bone cancer	0.000424	0.00313	CcSEcCtD
Dorzolamide—Sweating—Methotrexate—bone cancer	0.000419	0.00309	CcSEcCtD
Dorzolamide—Feeling abnormal—Cisplatin—bone cancer	0.000418	0.00309	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—bone cancer	0.000415	0.00306	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—bone cancer	0.000413	0.00305	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—bone cancer	0.000413	0.00305	CcSEcCtD
Dorzolamide—Epistaxis—Methotrexate—bone cancer	0.000412	0.00304	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—bone cancer	0.000408	0.00301	CcSEcCtD
Dorzolamide—Agranulocytosis—Methotrexate—bone cancer	0.000407	0.00301	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000405	0.00299	CcSEcCtD
Dorzolamide—Body temperature increased—Cisplatin—bone cancer	0.000401	0.00296	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—bone cancer	0.000397	0.00293	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—bone cancer	0.000397	0.00293	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—bone cancer	0.000397	0.00293	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000394	0.00291	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—bone cancer	0.000392	0.00289	CcSEcCtD
Dorzolamide—Pharyngitis—Methotrexate—bone cancer	0.000389	0.00287	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—bone cancer	0.000385	0.00285	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—bone cancer	0.000384	0.00283	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—bone cancer	0.000383	0.00283	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—bone cancer	0.000382	0.00282	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—bone cancer	0.000381	0.00282	CcSEcCtD
Dorzolamide—Visual impairment—Methotrexate—bone cancer	0.000378	0.00279	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000375	0.00277	CcSEcCtD
Dorzolamide—Hypersensitivity—Cisplatin—bone cancer	0.000374	0.00276	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—bone cancer	0.000373	0.00276	CcSEcCtD
Dorzolamide—Erythema multiforme—Methotrexate—bone cancer	0.000371	0.00274	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—bone cancer	0.000367	0.00271	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—bone cancer	0.000367	0.00271	CcSEcCtD
Dorzolamide—Tinnitus—Methotrexate—bone cancer	0.000365	0.0027	CcSEcCtD
Dorzolamide—Asthenia—Cisplatin—bone cancer	0.000364	0.00269	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—bone cancer	0.000364	0.00269	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—bone cancer	0.000362	0.00268	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—bone cancer	0.000357	0.00263	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—bone cancer	0.000355	0.00262	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—bone cancer	0.000353	0.00261	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—bone cancer	0.000353	0.00261	CcSEcCtD
Dorzolamide—Diarrhoea—Cisplatin—bone cancer	0.000347	0.00256	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—bone cancer	0.000347	0.00256	CcSEcCtD
Dorzolamide—Alopecia—Methotrexate—bone cancer	0.000346	0.00256	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—bone cancer	0.000346	0.00255	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—bone cancer	0.000342	0.00253	CcSEcCtD
Dorzolamide—Erythema—Methotrexate—bone cancer	0.000341	0.00252	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—bone cancer	0.000337	0.00249	CcSEcCtD
Dorzolamide—Dysgeusia—Methotrexate—bone cancer	0.000334	0.00247	CcSEcCtD
Dorzolamide—Back pain—Methotrexate—bone cancer	0.00033	0.00244	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—bone cancer	0.000328	0.00242	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—bone cancer	0.000327	0.00242	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—bone cancer	0.000324	0.00239	CcSEcCtD
Dorzolamide—Vomiting—Cisplatin—bone cancer	0.000323	0.00238	CcSEcCtD
Dorzolamide—Vision blurred—Methotrexate—bone cancer	0.000322	0.00237	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—bone cancer	0.000321	0.00237	CcSEcCtD
Dorzolamide—Rash—Cisplatin—bone cancer	0.00032	0.00236	CcSEcCtD
Dorzolamide—Dermatitis—Cisplatin—bone cancer	0.00032	0.00236	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—bone cancer	0.000319	0.00236	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—bone cancer	0.000316	0.00234	CcSEcCtD
Dorzolamide—Tension—Epirubicin—bone cancer	0.000313	0.00231	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—bone cancer	0.000313	0.00231	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—bone cancer	0.00031	0.00229	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—bone cancer	0.000309	0.00228	CcSEcCtD
Dorzolamide—Vertigo—Methotrexate—bone cancer	0.000307	0.00226	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—bone cancer	0.000303	0.00224	CcSEcCtD
Dorzolamide—Nausea—Cisplatin—bone cancer	0.000301	0.00223	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—bone cancer	0.000301	0.00222	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—bone cancer	0.0003	0.00221	CcSEcCtD
Dorzolamide—Cough—Methotrexate—bone cancer	0.000298	0.0022	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—bone cancer	0.000295	0.00218	CcSEcCtD
Dorzolamide—Chest pain—Methotrexate—bone cancer	0.00029	0.00215	CcSEcCtD
Dorzolamide—Arthralgia—Methotrexate—bone cancer	0.00029	0.00215	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—bone cancer	0.00029	0.00214	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—bone cancer	0.000289	0.00214	CcSEcCtD
Dorzolamide—Discomfort—Methotrexate—bone cancer	0.000287	0.00212	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—bone cancer	0.000287	0.00212	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—bone cancer	0.000287	0.00212	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—bone cancer	0.000286	0.00211	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—bone cancer	0.000286	0.00211	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—bone cancer	0.000282	0.00208	CcSEcCtD
Dorzolamide—Confusional state—Methotrexate—bone cancer	0.000281	0.00207	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—bone cancer	0.000281	0.00207	CcSEcCtD
Dorzolamide—Cough—Epirubicin—bone cancer	0.000279	0.00206	CcSEcCtD
Dorzolamide—Anaphylactic shock—Methotrexate—bone cancer	0.000278	0.00206	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—bone cancer	0.000278	0.00206	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—bone cancer	0.000276	0.00204	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—bone cancer	0.000272	0.00201	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—bone cancer	0.000272	0.00201	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—bone cancer	0.000271	0.002	CcSEcCtD
Dorzolamide—Hyperhidrosis—Methotrexate—bone cancer	0.000269	0.00199	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—bone cancer	0.000269	0.00198	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—bone cancer	0.000266	0.00196	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—bone cancer	0.000265	0.00196	CcSEcCtD
Dorzolamide—Anorexia—Methotrexate—bone cancer	0.000265	0.00196	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—bone cancer	0.000265	0.00196	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—bone cancer	0.000263	0.00194	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—bone cancer	0.000261	0.00193	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—bone cancer	0.000261	0.00192	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—bone cancer	0.000261	0.00192	CcSEcCtD
Dorzolamide—Hypotension—Methotrexate—bone cancer	0.00026	0.00192	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—bone cancer	0.00026	0.00192	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—bone cancer	0.000258	0.0019	CcSEcCtD
Dorzolamide—Shock—Epirubicin—bone cancer	0.000256	0.00189	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—bone cancer	0.000255	0.00188	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000254	0.00187	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—bone cancer	0.000252	0.00186	CcSEcCtD
Dorzolamide—Insomnia—Methotrexate—bone cancer	0.000252	0.00186	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—bone cancer	0.000252	0.00186	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—bone cancer	0.000252	0.00186	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—bone cancer	0.000251	0.00185	CcSEcCtD
Dorzolamide—Paraesthesia—Methotrexate—bone cancer	0.00025	0.00185	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—bone cancer	0.000249	0.00184	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—bone cancer	0.000248	0.00183	CcSEcCtD
Dorzolamide—Dyspnoea—Methotrexate—bone cancer	0.000248	0.00183	CcSEcCtD
Dorzolamide—Somnolence—Methotrexate—bone cancer	0.000248	0.00183	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—bone cancer	0.000246	0.00182	CcSEcCtD
Dorzolamide—Dyspepsia—Methotrexate—bone cancer	0.000245	0.00181	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—bone cancer	0.000244	0.0018	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—bone cancer	0.000243	0.0018	CcSEcCtD
Dorzolamide—Decreased appetite—Methotrexate—bone cancer	0.000242	0.00179	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—bone cancer	0.000241	0.00178	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—bone cancer	0.000241	0.00178	CcSEcCtD
Dorzolamide—Fatigue—Methotrexate—bone cancer	0.00024	0.00177	CcSEcCtD
Dorzolamide—Pain—Methotrexate—bone cancer	0.000238	0.00176	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000237	0.00175	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—bone cancer	0.000237	0.00175	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—bone cancer	0.000236	0.00174	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—bone cancer	0.000234	0.00173	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—bone cancer	0.000233	0.00172	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—bone cancer	0.000232	0.00172	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—bone cancer	0.000232	0.00171	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—bone cancer	0.00023	0.0017	CcSEcCtD
Dorzolamide—Feeling abnormal—Methotrexate—bone cancer	0.000229	0.00169	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—bone cancer	0.000229	0.00169	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Methotrexate—bone cancer	0.000228	0.00168	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—bone cancer	0.000227	0.00167	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—bone cancer	0.000225	0.00166	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—bone cancer	0.000225	0.00166	CcSEcCtD
Dorzolamide—Pain—Epirubicin—bone cancer	0.000223	0.00165	CcSEcCtD
Dorzolamide—Urticaria—Methotrexate—bone cancer	0.000221	0.00163	CcSEcCtD
Dorzolamide—Abdominal pain—Methotrexate—bone cancer	0.00022	0.00163	CcSEcCtD
Dorzolamide—Body temperature increased—Methotrexate—bone cancer	0.00022	0.00163	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00022	0.00162	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—bone cancer	0.000218	0.00161	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—bone cancer	0.000217	0.0016	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—bone cancer	0.000215	0.00159	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—bone cancer	0.000215	0.00159	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—bone cancer	0.000214	0.00158	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—bone cancer	0.000213	0.00157	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—bone cancer	0.000212	0.00157	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—bone cancer	0.00021	0.00155	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—bone cancer	0.000208	0.00154	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—bone cancer	0.000207	0.00153	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—bone cancer	0.000206	0.00152	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—bone cancer	0.000206	0.00152	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—bone cancer	0.000206	0.00152	CcSEcCtD
Dorzolamide—Hypersensitivity—Methotrexate—bone cancer	0.000205	0.00152	CcSEcCtD
Dorzolamide—Asthenia—Methotrexate—bone cancer	0.0002	0.00148	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—bone cancer	0.000199	0.00147	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000197	0.00146	CcSEcCtD
Dorzolamide—Pruritus—Methotrexate—bone cancer	0.000197	0.00145	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—bone cancer	0.000192	0.00142	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—bone cancer	0.000192	0.00141	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—bone cancer	0.000191	0.00141	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—bone cancer	0.000191	0.00141	CcSEcCtD
Dorzolamide—Diarrhoea—Methotrexate—bone cancer	0.000191	0.00141	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—bone cancer	0.000187	0.00138	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—bone cancer	0.000184	0.00136	CcSEcCtD
Dorzolamide—Dizziness—Methotrexate—bone cancer	0.000184	0.00136	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—bone cancer	0.000178	0.00132	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—bone cancer	0.000178	0.00131	CcSEcCtD
Dorzolamide—Vomiting—Methotrexate—bone cancer	0.000177	0.00131	CcSEcCtD
Dorzolamide—Rash—Methotrexate—bone cancer	0.000176	0.0013	CcSEcCtD
Dorzolamide—Dermatitis—Methotrexate—bone cancer	0.000175	0.0013	CcSEcCtD
Dorzolamide—Headache—Methotrexate—bone cancer	0.000174	0.00129	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—bone cancer	0.000173	0.00128	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—bone cancer	0.000172	0.00127	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—bone cancer	0.000171	0.00126	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—bone cancer	0.000166	0.00122	CcSEcCtD
Dorzolamide—Nausea—Methotrexate—bone cancer	0.000165	0.00122	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—bone cancer	0.000165	0.00122	CcSEcCtD
Dorzolamide—Rash—Epirubicin—bone cancer	0.000164	0.00121	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—bone cancer	0.000164	0.00121	CcSEcCtD
Dorzolamide—Headache—Epirubicin—bone cancer	0.000163	0.00121	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—bone cancer	0.000159	0.00118	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—bone cancer	0.000155	0.00114	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—bone cancer	0.000153	0.00113	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—bone cancer	0.000152	0.00112	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—bone cancer	0.000152	0.00112	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—bone cancer	0.000151	0.00112	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—bone cancer	0.000143	0.00106	CcSEcCtD
